Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004800Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 1992
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of acellular pertussis vaccine in pertussis, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 1992; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT00004800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004800.